Stewart W. Strong - 26 Jul 2024 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Reporting relationship: President, Global Hospital
Issuer ticker: HAE
Reported as of: 26 Jul 2024
Net transaction value: -$393,039
SEC form: 4
Accepted by SEC: 29 Jul 2024, 17:03:35 UTC
Prior SEC filing: 26 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Strong

Key filing fact

Stewart W. Strong filed Form 4 for HAEMONETICS CORP (HAE) on 29 Jul 2024.

Key facts

This page summarizes Stewart W. Strong's Form 4 filing for HAEMONETICS CORP (HAE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Jul 2024, 17:03.

Change

Previous filing in this sequence was filed on 26 Jul 2024.
Current net transaction value: -$393,039.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HAE transaction

Common Stock

Sale

Transaction value: $393,039
Shares: -4,312
Change %: -19%
Price: $91.15
Shares after: 18,196
Date: 26 Jul 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023).

Footnote F2

This number includes unvested restricted stock units previously reported.